Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 05, 2026 Filed Jan 6, 2026 16:51 UTC GrantCommon Stock 21 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-000319 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,023.102

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 16:51 UTC GrantCommon Stock 62 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-000319 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,002.102

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 15:13 UTC
keller brettDirector
GrantCommon Stock 138 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009848 · doc4.xml · nonDerivative · entry 1

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,654

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 15:13 UTC GrantCommon Stock 299 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009850 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,842

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 15:13 UTC GrantCommon Stock 149 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009851 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,136

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 15:13 UTC
Zavery AmitDirector
GrantCommon Stock 138 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009852 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,481

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 15:13 UTC GrantCommon Stock 160 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009849 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,940.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 15:21 UTC GiftCommon Stock 5,709 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009792 · doc4.xml · nonDerivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,576.0271

F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 19:02 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $148.07 $0.00
Disclosure

SEC source: 0001225208-25-009654 · doc4.xml · derivative · entry 7

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,548

Underlying: Common Stock · 6,000 shares

Expires 2031-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 19:02 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 4,163 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-25-009654 · doc4.xml · derivative · entry 6

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,163 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 19:02 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 5,548 $229.26 $1,271,910.62
Disclosure

SEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 5

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,026

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.89 - $229.71, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 19:02 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 3,516 $229.26 $806,063.04
Disclosure

SEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 4

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,574

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.89 - $229.71, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 19:02 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 1,150 $229.26 $263,644.06
Disclosure

SEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 3

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,090

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.89 - $229.71, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 19:02 UTC
Carey Thomas PCorporate VP
Exercise / conversionCommon Stock 4,163 $93.88 $390,822.44
Disclosure

SEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 2

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,240

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 19:02 UTC
Carey Thomas PCorporate VP
Exercise / conversionCommon Stock 6,000 $148.07 $888,420.00
Disclosure

SEC source: 0001225208-25-009654 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 18, 2025 Filed Nov 18, 2025 16:09 UTC SaleCommon Stock 3,984 $226.00 $900,384.00
Disclosure

SEC source: 0001225208-25-009263 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,828.521

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantStock Option (Right to Buy) · Derivative 1,758 $0.00 Strike: $225.61 $0.00
Disclosure

SEC source: 0001225208-25-009243 · doc4.xml · derivative · entry 5

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,758

Underlying: Common Stock · 1,758 shares

Expires 2035-11-13

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantCommon Stock 459 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009243 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,977

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantStock Option (Right to Buy) · Derivative 1,758 $0.00 Strike: $225.61 $0.00
Disclosure

SEC source: 0001225208-25-009244 · doc4.xml · derivative · entry 2

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,758

Underlying: Common Stock · 1,758 shares

Expires 2035-11-13

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantCommon Stock 459 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009244 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,649

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC
keller brettDirector
GrantStock Option (Right to Buy) · Derivative 1,758 $0.00 Strike: $225.61 $0.00
Disclosure

SEC source: 0001225208-25-009245 · doc4.xml · derivative · entry 2

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,758

Underlying: Common Stock · 1,758 shares

Expires 2035-11-13

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC
keller brettDirector
GrantCommon Stock 459 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009245 · doc4.xml · nonDerivative · entry 1

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,516

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantStock Option (Right to Buy) · Derivative 3,182 $0.00 Strike: $225.61 $0.00
Disclosure

SEC source: 0001225208-25-009247 · doc4.xml · derivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,182

Underlying: Common Stock · 3,182 shares

Expires 2035-11-13

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009247 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,543

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:40 UTC
Zavery AmitDirector
GrantStock Option (Right to Buy) · Derivative 1,758 $0.00 Strike: $225.61 $0.00
Disclosure

SEC source: 0001225208-25-009249 · doc4.xml · derivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,758

Underlying: Common Stock · 1,758 shares

Expires 2035-11-13

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:40 UTC
Zavery AmitDirector
GrantCommon Stock 459 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009249 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,343

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantStock Option (Right to Buy) · Derivative 1,758 $0.00 Strike: $225.61 $0.00
Disclosure

SEC source: 0001225208-25-009248 · doc4.xml · derivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,758

Underlying: Common Stock · 1,758 shares

Expires 2035-11-13

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantCommon Stock 459 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009248 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,987

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantStock Option (Right to Buy) · Derivative 1,758 $0.00 Strike: $225.61 $0.00
Disclosure

SEC source: 0001225208-25-009246 · doc4.xml · derivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,758

Underlying: Common Stock · 1,758 shares

Expires 2035-11-13

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 18:39 UTC GrantCommon Stock 459 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-009246 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,780.102

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 85 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008411 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,518

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 9 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008412 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,190

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC
keller brettDirector
GrantCommon Stock 16 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008413 · doc4.xml · nonDerivative · entry 2

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,057

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC
keller brettDirector
GrantCommon Stock 35 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008413 · doc4.xml · nonDerivative · entry 1

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,041

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 7 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008415 · doc4.xml · nonDerivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,712

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 7 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008415 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,705

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC
Zavery AmitDirector
GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008417 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,884

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC
Zavery AmitDirector
GrantCommon Stock 17 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008417 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,870

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 9 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008416 · doc4.xml · nonDerivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,528

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 10 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008416 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,519

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 19 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008414 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,321.102

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 57 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008414 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,302.102

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 14:35 UTC GrantCommon Stock 21 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008410 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,282

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
September 17, 2025 Filed Sep 19, 2025 14:25 UTC
keller brettDirector
GrantCommon Stock 121 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008099 · doc4.xml · nonDerivative · entry 1

keller brett · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,006

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
September 17, 2025 Filed Sep 19, 2025 14:25 UTC GrantCommon Stock 167 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008100 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,698

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
September 17, 2025 Filed Sep 19, 2025 14:25 UTC GrantCommon Stock 140 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008103 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,245.102

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
September 17, 2025 Filed Sep 19, 2025 14:25 UTC
Zavery AmitDirector
GrantCommon Stock 121 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008102 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,853

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
September 17, 2025 Filed Sep 19, 2025 14:25 UTC GrantCommon Stock 121 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008101 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,509

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
August 25, 2025 Filed Aug 26, 2025 14:39 UTC SaleCommon Stock 5,674 $258.37 $1,466,010.10
Disclosure

SEC source: 0001225208-25-007473 · doc4.xml · nonDerivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 143,285.0271

F1 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.24 - $262.46, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 20:25 UTC SaleCommon Stock 5,675 $260.87 $1,480,427.60
Disclosure

SEC source: 0001225208-25-007318 · doc4.xml · nonDerivative · entry 1

Gokey Timothy C · CIK 0001296187 · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,959.0271

F1 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person May 14, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.02 - $261.76, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.